| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/20/2009 | CN100488980C Integrin binding motif containing peptides and its uses |
| 05/20/2009 | CN100488567C Cancer gene therapeutic drug |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/19/2009 | US7534939 Bacillus thuringiensis strains comprising novel crystal proteins which exhibit insecticidal activity against lepidopteran insects |
| 05/19/2009 | US7534935 Phospholipid:diacylglycerol acyltransferases |
| 05/19/2009 | US7534934 genetically enhancing the nutritional value/agronomic performance without permanent or stable incorporation of unknown/foreign DNA into plant genome |
| 05/19/2009 | US7534933 Preparing disease, freeze and drought resistant transgenic plants |
| 05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
| 05/19/2009 | US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/19/2009 | US7534874 Gene involved in V(D)J recombination and/or DNA repair |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534865 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534864 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534863 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 05/19/2009 | US7534862 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders |
| 05/19/2009 | US7534861 Compositions and methods for immunoaffinity purification |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/19/2009 | US7534786 Inhibition of tau-tau association |
| 05/19/2009 | US7534775 Methods and compositions for modulating cardiac contractility |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/19/2009 | US7534762 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 05/19/2009 | US7534761 Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom |
| 05/19/2009 | US7534604 Fusion polypeptides capable of activating receptors |
| 05/19/2009 | US7534603 Fusion protein delivery system and uses thereof |
| 05/19/2009 | US7534602 Promoters and usage thereof |
| 05/19/2009 | US7534585 Multifunctional cytokines |
| 05/19/2009 | US7534580 Invention identifies carrier protein to which PSP94 is bound (named PSP94-binding protein), its nucleic acid and amino acid sequences; use in diagnosis and prognosis of PSP94 related disease |
| 05/19/2009 | US7534577 Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
| 05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
| 05/19/2009 | US7534573 comprising transfecting said neurons with a nucleic acid encoding a protein that is targeted to synaptic vesicles and that fluoresces when synaptic vesicles undergo exocytosis; for use in treating epilepsy and other brain disorders |
| 05/19/2009 | US7534571 ligand (referred to herein as "TREM-1-Ligand") of a myeloid cell receptor called TREM-1 (referred to herein as "TREM-1-Receptor") is a specific marker for bacterial and fungal sepsis |
| 05/19/2009 | US7534565 Using decreased expression of deleted in liver cancer 1(DLC-1) as diagnostic indicator of cell proliferative disorders in breast, collon and liver |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534559 Feline polynucleotide vaccine formula |
| 05/19/2009 | US7534558 In vitro diagnostic test for enterovirus infections |
| 05/19/2009 | US7534449 Targeted and high density drug loaded polymeric materials |
| 05/19/2009 | US7534448 encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface; tissue engineering matrices, wound dressings, bone repair or regeneration materials |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534438 Reducing viscosity, cohesion; mixture containing thioreodxin; cystic fibrosis |
| 05/19/2009 | US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection |
| 05/19/2009 | US7534436 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/19/2009 | US7534435 Glycosylated specificity exchangers |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534428 Antibodies to tumor necrosis factor receptors 6α and 6β |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |
| 05/19/2009 | CA2400966C Rat model with the onset of prostate cancer |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
| 05/19/2009 | CA2318029C Apo-2 ligand |
| 05/19/2009 | CA2247071C Dna vaccination for induction of suppressive t cell response |
| 05/19/2009 | CA2237643C Therapeutic agent for acute hepatic failure |
| 05/19/2009 | CA2230511C Flowering genes |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/14/2009 | WO2009062195A2 Fusion proteins of mannose binding lectins for treatment of disease |
| 05/14/2009 | WO2009062170A1 Molecular affinity clamp technology and uses thereof |
| 05/14/2009 | WO2009062100A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 05/14/2009 | WO2009062034A1 Methods, compositions, and sequences of zp-binding peptides for immunocontraception of dogs and other animals |
| 05/14/2009 | WO2009061853A2 Mutant interleukin-2 (il-2) polypeptides |
| 05/14/2009 | WO2009061847A2 Methods for diagnosing and treating pelvic pain disorders via beta-catenin |
| 05/14/2009 | WO2009061807A2 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 05/14/2009 | WO2009061798A1 Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine |
| 05/14/2009 | WO2009061739A1 Neutralization of hcv |
| 05/14/2009 | WO2009061381A2 Alpha-amylase variants with altered properties |
| 05/14/2009 | WO2009061368A1 Inhibition of versican with sirna and other molecules |
| 05/14/2009 | WO2009061216A1 Compositions and methods for altering the production of pigment in plants |
| 05/14/2009 | WO2009061215A1 Compositions and methods for altering pigment production in plants |
| 05/14/2009 | WO2009061214A1 Compositions and methods for modulating pigment production in plants |
| 05/14/2009 | WO2009061186A1 Method for preparing food product |
| 05/14/2009 | WO2009061130A2 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 05/14/2009 | WO2009060961A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | WO2009060804A1 Mutant nucleic acid associated with chronic myeloproliferative disorder, and method for evaluation of chronic myeloproliferative disorder |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009060316A2 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 05/14/2009 | WO2009060229A1 Sulfatase enzymes |
| 05/14/2009 | WO2009060225A2 Rodenticide |
| 05/14/2009 | WO2009060184A1 Mycobacterium antigens |
| 05/14/2009 | WO2009060159A1 Mutated ilt molecules |
| 05/14/2009 | WO2009060071A1 Insulin derivative |
| 05/14/2009 | WO2009059804A2 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells |
| 05/14/2009 | WO2009059755A2 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | WO2009059422A1 Rotavirus vaccine |
| 05/14/2009 | WO2009042910A9 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 05/14/2009 | WO2009042565A3 Inhibitors of eppin/semenogelin binding as male contraceptives |
| 05/14/2009 | WO2009042194A3 Methods of synthesis for therapeuthic anti-hiv peptides |
| 05/14/2009 | WO2009042162A3 Compositions and methods for inhibiting interleukin pathways |
| 05/14/2009 | WO2009039854A3 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 05/14/2009 | WO2009037402A3 Hpiv-2 variants and medical applications thereof |
| 05/14/2009 | WO2009035770A3 Cholera toxin subunit b conjugated quantum dots for live cell labelling |
| 05/14/2009 | WO2009029132A3 Antigen-binding proteins targeting s. aureus orf0657n |
| 05/14/2009 | WO2009025846A3 Activatable binding polypeptides and methods of identification and use thereof |
| 05/14/2009 | WO2009020867A3 Immunomodulatory peptides |